2001

May 21, 2001
Guidant Announces Two New Members to its Board of Directors

Former HCFA Administrator and Current Eli Lilly and Company Executive Vice President Added to the Board Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT) announced that Guidant's...

May 21, 2001
Guidant Provides Product Updates at Annual Meeting of Shareholders

Emerging Therapies Position Company for Future Success Indianapolis, Ind. - Ronald W. Dollens, president and CEO of Guidant Corporation (NYSE and PCX: GDT), today provided a positive forecast of...

May 18, 2001
Guidant Announces Live Webcast of its Paris Course Investor Briefing

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular therapy technology, today announced that it will host a live webcast of its briefing at the...

May 18, 2001
Guidant Announces FDA Approval of its Newest Non-Coronary Stent System

Company's Second Non-Coronary Stent System Approved Within the Past Month Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

May 9, 2001
Guidant Poised for U.S. Launch of Newest Coronary Stent System

Company Receives FDA Approval of MULTI-LINK PENTA Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of coronary artery disease,...

May 8, 2001
Guidant To Participate in Deutsche Banc Alex. Brown's Health Care Conference

>Guidant Presentation Accessible Via Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today announced that it will...

May 4, 2001
Statement from Guidant Corporation Regarding Heart Failure Trial Press Release

Indianapolis, IN and St. Paul, MN - Late this afternoon, various news organizations quoted a U.S. Food and Drug Administration (FDA) spokesperson who commented on Guidant's May 2 release...

May 4, 2001
Guidant Announces First Implant of Ventricular Defibrillator Providing Advanced Atrial Therapies

PRIZM AVT Pulse Generator Receives European CE Mark Approval Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology, today...

May 3, 2001
Guidant Introduces its Most Sophisticated Pacemaker in the U.S.

System Combines Sensor and Diagnostic Capabilities to Enhance Therapy Delivery Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular...

May 2, 2001
Guidant Completes Heart Failure Trial; Study Designed to Determine Benefits of Combined Cardiac Resynchronization and Defibrillation Therapies

Guidant's System Designed to Treat Heart Failure and Prevent Sudden Cardiac Death. Trial Results Suggest a Slowing of Heart Failure Progression, Improvements in Functional Capacity and Quality of...

Apr 30, 2001
Guidant Announces First Implant of Next Generation Heart Failure Device

Heart Failure Technology Deemed Fileable on an Expedited Basis Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT) today announced the first implant of the CONTAK...

Apr 24, 2001
Guidant Foundation Invests in American Heart Association Heart Failure Initiative

Grant to AHA will Empower Americans with Comprehensive Knowledge About Cardiovascular Disease and Heart Failure Indianapolis, Ind. - The Guidant Foundation today announced that it has presented a...

Apr 23, 2001
Guidant Notifies Physicians of Defibrillators Switching into Built-in Safety Mode

Field Action Results in One-Time Charge to First Quarter Earnings Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in cardiac and vascular technology,...

Apr 23, 2001
Guidant Reports All Time Record Sales And Pre-Charge Earnings

Sales Reach $671 million and Generate Adjusted Earnings per share of $0.41 Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a global leader in technology for the treatment of cardiac...

Apr 23, 2001
Guidant Announces Stock Repurchase Program

Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced that it intends to repurchase up to $200 million of its common shares...

Apr 19, 2001
Study Shows Value of Implantable Defibrillation Therapy vs. Drugs

Guidant to Apply for New Indication Based on Study Results Indianapolis, IN, and St. Paul, MN - Results of the first clinical study to demonstrate that implantable cardioverter defibrillators...

Apr 18, 2001
Guidant Announces Live Webcast of its First Quarter Earnings Conference Call

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its first quarter 2001 earnings conference call on...

Apr 18, 2001
Guidant Announces European Approval and FDA Filing of MULTI-LINK PIXEL Coronary Stent System

New System Allows Physicians to Treat Wider Range of Coronary Blockages Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Apr 10, 2001
Guidant Pre-Announces All-Time Record Quarterly Sales and Earnings

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced revenue of $671 million and adjusted earnings of $126.9 million for...

Apr 5, 2001
Guidant Supports Fellows Course to Educate Future Interventional Cardiologists

International Symposium Covers Latest Techniques and Technologies for Treating Coronary and Peripheral Vascular Disease Indianapolis, Ind. and Santa Clara, Calif. - In an effort to equip the next...

Mar 27, 2001
Guidant Announces Nomination of Former HCFA Administrator to Its Board of Directors

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, today announced that its Board of Directors has nominated Nancy-Ann DeParle to...

Mar 26, 2001
Guidant's Intravascular Radiotherapy System Enjoys Continued Success in Europe

Company Satisfies European Post-Marketing Requirements for its GALILEO System Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Mar 20, 2001
Clinical Study Demonstrates Decreased Risk of Neurological Complications for Patients Undergoing Beating Heart Surgery

Indianapolis, Ind. and Cupertino, Calif. - Data from a recent clinical study1 show that among patients experiencing neurological complications after coronary artery bypass surgery, those who...

Mar 16, 2001
Guidant Attains U.S. Coronary Angioplasty Market Leadership, Reinforcing its Position as the Global Leader in Interventional Cardiology

Company Announces Worldwide Approval of POWERSAIL and HIGHSAIL Coronary Dilatation Catheters Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT) a world leader in...

Mar 16, 2001
Guidant Voluntarily Halts Production and Sales of Endovascular Graft

Patients With Implanted Devices Not Affected by this Action Indianapolis, IN and Menlo Park, CA - Guidant Corporation (NYSE and PCX: GDT) today announced it has voluntarily halted production and...

Mar 15, 2001
Guidant to Host General Briefing at the American College of Cardiology Meeting

All Are Invited to Access the Guidant Briefing By Live Webcast Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will host a general...

Feb 28, 2001
Guidant Announces FDA Filing for Heart Failure Treatment

Company First to File for Approval of Cardiac Resynchronization Therapy Defibrillator for Heart Failure Patients Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX:GDT), a...

Feb 21, 2001
Guidant Expands its Product Offerings for the Treatment of Coronary Artery Disease

Company Receives CE Mark Approval on Latest Coronary Stent System and Filed for U.S. Approval Earlier This Year Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX:...

Feb 16, 2001
Guidant Launches New Coronary Stent System in Japan

Company Also Increases Direct Sales Organization to Support New Product Introductions Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Feb 6, 2001
Guidant's Drug Eluting Stent System Shown to Reduce Restenosis in Pre-Clinical Models

Human Evaluation Expected to Begin in the Second Quarter of This Year Indianapolis, Ind. and Santa Clara, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of...

Feb 5, 2001
Guidant to Participate in Merrill Lynch Global Healthcare Conference

Investors Are Invited to Access the Guidant Presentation by Live Webcast INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, today announced that it...

Jan 30, 2001
Guidant Reports Fourth Quarter Sales Increase of 13 Percent to $649 Million; Record Fourth Quarter Earnings, as Adjusted, of $0.41 per Share

Full Year Net Income Grew 20 Percent, as Adjusted Indianapolis, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, today reported fourth quarter sales were $648.8...

Jan 29, 2001
Guidant Introduces New Beating Heart Coronary Artery Bypass Platform

Indianapolis, Ind. and Cupertino, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular disease, announced today the introduction of a new product...

Jan 29, 2001
Guidant Announces Live Webcast of its Fourth Quarter and Year-End 2000 Earnings Conference Call

INDIANAPOLIS, IN - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, will conduct a live webcast of its fourth quarter and year-end 2000 earnings...

Jan 29, 2001
Guidant to Focus Heart Failure Efforts on Cardiac Resynchronization Therapy

Opts not to Acquire Impulse Dynamics Technology; Will Recognize Charge in Fourth Quarter of 2000 Indianapolis, IN and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a world leader in...

Jan 29, 2001
Guidant Organizes to Enhance Focus on New Therapies

Company Forms Endovascular Solutions and Guidant Cardiac Surgery Groups Indianapolis, Ind. and Santa Clara and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the...

Jan 29, 2001
Guidant Announces Comprehensive Web Site With Patient- and Physician-Friendly Focus

New Site Responds to Consumer Interest in Healthcare Information Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in medical technology, announced today its new...

Jan 26, 2001
Guidant to Host Investor Briefing at American College of Cardiology Meeting
Jan 26, 2001
New Study Shows Guidant's Heart Failure Technology Delivers a Marked Improvement for a Solid Majority of Patients

Company's CONTAK Registry Reflects Experience of 1,000 European Heart Failure Patients Indianapolis, IN, and St. Paul, MN - Guidant Corporation (NYSE and PCX: GDT), a global leader in heart...

Jan 4, 2001
Guidant Pre-Announces Fourth Quarter Revenues and Impact on Earnings Per Share

Indianapolis, Ind. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the medical technology industry, announced fourth quarter revenues of approximately $649 million, reflecting sales...

Jul 19, 2001
First Patients in Japan Treated with Guidant's Carotid Stent

Clinical Study to Evaluate Novel Stroke Prevention Alternative for Japanese Patients Indianapolis, Ind. and Tokyo, Japan - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment...

Apr 19, 2001
Guidant Expands Company's Non-Coronary Stent Offering

Indianapolis, Ind. and Menlo Park, Calif. - Guidant Corporation (NYSE and PCX: GDT), a world leader in the treatment of cardiovascular and vascular disease, announced today it has received...

Show 5102550100 per page
Top